Pacira BioSciences PCRX
NASDAQ PCRX
$36.49 +0.03 (+0.07%)
As of: Nov 10, 2026 · 2:29 PM EST

Pacira BioSciences (PCRX) Net Short-Term Debt Issued (Repaid) (2010 - 2026)

Updated

Analysis

Pacira BioSciences (PCRX) Net Short-Term Debt Issued (Repaid) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -4.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -24.00 Mn
10 Pacira BioSciences 1.45 Bn 466.99 Mn 139.42 Mn -70.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -70.00 Mn
Jun 30, 2026 -5.00 Mn
Mar 31, 2026 -5.00 Mn
Dec 31, 2025 -5.00 Mn
Sep 30, 2025 -5.00 Mn
Dec 31, 2023 -149.55 Mn
Mar 31, 2023 149.55 Mn
Sep 30, 2010 5.63 Mn
API Access

Pacira BioSciences Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=PCRX&period=max&api_key=YOUR_API_KEY